Observational Study
Copyright ©The Author(s) 2015.
World J Hepatol. Oct 8, 2015; 7(22): 2418-2426
Published online Oct 8, 2015. doi: 10.4254/wjh.v7.i22.2418
Table 3 Univariate and multivariate logistic analysis to determine predictors for risk of non sero-protection n (%)
VariableNon-seroprotection rateCrude odds ratio (95%CI)AOR (95%CI)
Age in years
< 5152 (13.6)®®
5 to < 10256 (34.7)3.4 (2.7-4.2)b3.3 (2.5-4.2)b
10 to < 15606 (59.1)9.1 (7.4-11.3)b9.1 (7.3-11.2)b
≥ 15571 (69.5)14.5 (11.5-18.1)b14.2 (11.3-17.9)b
Gender
Boys681 (39.2)®®
Girls854 (46.2)1.3 (1.2-1.5)b1.1 (1.0-1.4)b

  • Citation: Salama II, Sami SM, Said ZNA, El-Sayed MH, El Etreby LA, Rabah TM, Elmosalami DM, Abdel Hamid AT, Salama SI, Abdel Mohsen AM, Emam HM, Elserougy SM, Hassanain AI, Abd Alhalim NF, Shaaban FA, Hemeda SA, Ibrahim NA, Metwally AM. Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter national project. World J Hepatol 2015; 7(22): 2418-2426
  • URL: https://www.wjgnet.com/1948-5182/full/v7/i22/2418.htm
  • DOI: https://dx.doi.org/10.4254/wjh.v7.i22.2418